Cargando…
An Up-to-Date Anti-Cancer Treatment Strategy Focusing on HIF-1α Suppression: Its Application for Refractory Ovarian Cancer
Hypoxia inducible factor-1α (HIF-1α) predominantly determines the transcriptional activity of HIF-1, which induces the certain genetic expressions to participate in the proliferation and progression of the tumor. It is supposed that HIF-1α is also an extremely important factor in cancer treatment. B...
Autores principales: | Fujita, Mariko, Yasuda, Masanori, Kitatani, Kanae, Miyazawa, Masaki, Hirabayashi, Kenichi, Takekoshi, Susumu, Iida, Tetsuji, Hirasawa, Takeshi, Murakami, Masaru, Mikami, Mikio, Ishiwata, Isamu, Shimizu, Michio, Osamura, R. Yoshiyuki |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Japan Society of Histochemistry and Cytochemistry
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2156042/ https://www.ncbi.nlm.nih.gov/pubmed/18224245 http://dx.doi.org/10.1267/ahc.07024 |
Ejemplares similares
-
Alterations in Mucin Expression in Ovarian Mucinous Tumors: Immunohistochemical Analysis of MUC2, MUC5AC, MUC6, and CD10 Expression
por: Hirabayashi, Kenichi, et al.
Publicado: (2008) -
Analysis of mTOR Inhibition-Involved Pathway in Ovarian Clear Cell Adenocarcinoma
por: Harasawa, Makiko, et al.
Publicado: (2011) -
A Histopathological Study of Multi-hormone Producing Proliferative Lesions in Estrogen-induced Rat Pituitary Prolactinoma
por: Takekoshi, Susumu, et al.
Publicado: (2014) -
Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma
por: Tsukada, Hitomi, et al.
Publicado: (2012) -
Treatment Strategy for Recurrent and Refractory Epithelial Ovarian Cancer: Efficacy of High-Dose Chemotherapy with Hematopoietic Stem Cell Transplantation
por: Muramatsu, Toshinari, et al.
Publicado: (2006)